Skinmed

Journal PubWeight™ 288.22‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Cutaneous signs. 2003 2.04
2 Continuing Medical Education II: MOC, CME, ABD, ABMS, ACGME, CMS, FSMB, IOM, MOL, PQRS, SMB, etcetera et ad nauseum. 2013 2.02
3 Editing a dermatology journal and the Council of Dermatology Editors. 2003 1.95
4 Skin disease in a primary care practice. 2005 1.56
5 A case of paracetamol-induced acute generalized exanthematous pustulosis in a pregnant woman localized in the neck region. 2004 1.51
6 Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II. 2003 1.50
7 How do you foster medication adherence for better acne vulgaris management? 2003 1.47
8 Vitiligo and alopecia areata associated with subclinical/clinical hypothyroidism. 2011 1.46
9 Is the distinction between superficial pressure ulcers and moisture lesions justifiable? A clinical-pathologic study. 2007 1.45
10 Longitudinal erythronychia: the value of cosmetic alterations in nail findings. 2011 1.45
11 Basal cell carcinoma. 2014 1.42
12 Eponyms in dermatology. 2004 1.41
13 Past and future: porphyria and porphyrins. 2005 1.41
14 Primary anetoderma: a cutaneous marker of antiphospholipid antibodies. 2011 1.41
15 Jumping into the future using teledermoscopy. 2003 1.41
16 Treatment options: herpes simplex viruses. 2004 1.41
17 Annular Elastolytic Giant Cell Granuloma and Temporal Arteritis Following Herpes Zoster. 2015 1.40
18 Zosteriform Staphylococcus aureus Cutaneous Infection: Report of Two Patients With Dermatomal Bacterial Infection. 2015 1.40
19 Exclusive plaque psoriasis of the lips: efficacy of combination therapy of topical tacrolimus, calcipotriol, and betamethasone dipropionate. 2012 1.40
20 The history of tuberous sclerosis complex: when skin gives a clue. 2015 1.40
21 A scientific soap opera and winter itch. 2004 1.40
22 PsEma--a hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema. 2005 1.39
23 Sentinel lymph node biopsy in melanoma: the gulf between presentation and reality. 2010 1.39
24 Patterns of chronic dermatoses in an Ethiopian central teaching hospital: a histopathologic approach. 2003 1.39
25 Cutaneous signs and syndromes associated with internal malignancies. 2005 1.38
26 Chlorpyrifos exacerbating pemphigus vulgaris: a preliminary report and suggested in vitro immunologic evaluation model. 2006 1.38
27 Granular parakeratosis: response to calcipotriene and brief review of current therapeutic options. 2011 1.38
28 Facial skin myiasis associated with advanced skin cancer: failure of early detection. 2006 1.38
29 Modesty and the skin: why they shouldn't mix. 2012 1.38
30 Dermatologic manifestations of complementary therapy. 2003 1.38
31 Is there a role for tumor necrosis factor-alpha inhibitors and especially thalidomide in dermatology? 2005 1.38
32 Foods, diet, and skin diseases. 2004 1.37
33 Nevus of Ota: clinical aspects and management. 2003 1.34
34 Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. 2006 1.14
35 Nerve injury and localized skin lesions: an instance of immunocompromised district. 2012 1.14
36 Pimecrolimus-induced tinea incognito. 2004 1.10
37 Kaposi's sarcoma mimicking a facial cyst as the presenting sign of human immunodeficiency virus. 2004 1.08
38 Germophobia: the dilemma of hand washing and protection from germs. 2012 1.07
39 Botulinum toxin and pregnancy. 2006 1.06
40 Alcohol-based disinfectants irritate and damage skin more than ordinary soap--true or false? 2012 1.06
41 Widespread Kaposi's sarcoma in an HIV-negative man. 2004 1.05
42 Posttraumatic lipoma: fact or fiction? 2007 1.02
43 Sister Mary Joseph's nodule as a presenting sign of internal malignancy. 2006 1.00
44 Smoking and psoriasis. 2005 0.99
45 Aggressive squamous cell carcinoma in Kindler syndrome. 2006 0.99
46 Diffuse alopecia in a child due to dietary zinc deficiency. 2007 0.98
47 Segmental neurofibromatosis and malignancy. 2010 0.95
48 Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%. 2006 0.95
49 Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution. 2005 0.94
50 Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. 2006 0.94
Next 50